| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Epidemiology Biomarkers & Prevention, Vol 7, Issue 1 13-18, Copyright © 1998 by American Association for Cancer Research
ARTICLES |
X Wu, CI Amos, BL Kemp, H Shi, H Jiang, Y Wan and MR Spitz
Department of Epidemiology, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.
Cytochrome P4502E1 (CYP2E1) is involved in the metabolic activation of carcinogenic N-nitrosamines. This study was performed to examine whether CYP2E1 DraI polymorphisms in intron 6 are related to susceptibility to lung cancer and are associated with carcinogenetic exposure. We therefore genotyped CYP2E1 by PCR amplification of peripheral WBC DNA from 126 patients with previously untreated lung cancer (85 African Americans and 41 Mexican Americans) and 193 controls (104 African Americans and 89 Mexican Americans). Mutagen sensitivity was measured with an in vitro assay quantitating bleomycin-induced chromatid breaks in peripheral blood lymphocyte cultures. The CYP2E1 DraI DD genotype was found in 86.5% of all cases and in 74.6% of all controls (P = 0.03), in 78.1% of 41 Mexican-American cases and in 69.6% of their controls (P = 0.70), and in 90.6% of African American cases and in 78.8% of their controls (P = 0.05). The DD genotype was found to be associated with a significantly higher risk of lung cancer overall with an odds ratio (OR) of 2.4 [95% confidence interval (CI), 1.1-5.3]. This risk was significantly elevated for men and for those who had ever smoked [ORs of 3.4 (95% CI, 1.3-8.7) and 2.6 (95% CI, 1.1-6.0), respectively], but not for women and nonsmokers [ORs of 0.7 (95% CI, 0.1-3.8) and 0.9 (95% CI, 0.1-10.6), respectively]. Stratified analysis showed an interaction that seemed greater than multiplicative between cigarette smoking and the CYP2E1 DraI DD genotype. The ORs for the CYP2E1 DraI DD genotype, cigarette smoking, and both risk factors combined were 1.5, 8.5, and 22.7, respectively. The CYP2E1 DraI polymorphism and the CYP2E1 PstI polymorphism in the upstream flanking regions were significantly associated in Mexican Americans but not in African Americans. We therefore conclude that the CYP2E1 DraI polymorphism seems to be associated with lung carcinogenesis. However, a larger study is warranted to evaluate the interactions among CYP2E1 DraI DD genotype, mutagen sensitivity, and cigarette smoking.
This article has been cited by other articles:
![]() |
G. Li, Z. Liu, E. M. Sturgis, R. M. Chamberlain, M. R. Spitz, and Q. Wei CYP2E1 G1532C, NQO1 Pro187Ser, and CYP1B1 Val432Leu Polymorphisms Are Not Associated with Risk of Squamous Cell Carcinoma of the Head and Neck Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 1034 - 1036. [Full Text] [PDF] |
||||
![]() |
S. M. Gadgeel, R. K. Severson, Y. Kau, J. Graff, L. K. Weiss, and G. P. Kalemkerian Impact of Race in Lung Cancer : Analysis of Temporal Trends From a Surveillance, Epidemiology, and End Results Database Chest, July 1, 2001; 120(1): 55 - 63. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. N. Nishimoto, T. Hanaoka, H. Sugimura, K. Nagura, M. Ihara, X.-J. Li, T. Arai, G. S. Hamada, L. P. Kowalski, and S. Tsugane Cytochrome P450 2E1 Polymorphism in Gastric Cancer in Brazil: Case-Control Studies of Japanese Brazilians and Non-Japanese Brazilians Cancer Epidemiol. Biomarkers Prev., July 1, 2000; 9(7): 675 - 680. [Abstract] [Full Text] |
||||
![]() |
H. Bartsch, U. Nair, A. Risch, M. Rojas, H. Wikman, and K. Alexandrov Genetic Polymorphism of CYP Genes, Alone or in Combination, as a Risk Modifier of Tobacco-related Cancers Cancer Epidemiol. Biomarkers Prev., January 1, 2000; 9(1): 3 - 28. [Abstract] [Full Text] |
||||
![]() |
N. Caporaso, N. Rothman, and S. Wacholder Case-Control Studies of Common Alleles and Environmental Factors J Natl Cancer Inst Monographs, December 1, 1999; 1999(26): 25 - 30. [Abstract] [Full Text] |
||||
![]() |
L. L. Marchand, G. R. Wilkinson, and L. R. Wilkens Genetic and Dietary Predictors of CYP2E1 Activity: A Phenotyping Study in Hawaii Japanese Using Chlorzoxazone Cancer Epidemiol. Biomarkers Prev., June 1, 1999; 8(6): 495 - 500. [Abstract] [Full Text] |
||||
![]() |
S. K. Chhabra, C. D. Reed, L. M. Anderson, and Y.-H. Shiao Comparison of the polymorphic regions of the cytochrome P450 CYP2E1 gene of humans and patas and cynomolgus monkeys Carcinogenesis, June 1, 1999; 20(6): 1031 - 1034. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |